Introduction
Xeroform gauze dressing — a fine-mesh cotton gauze impregnated with petrolatum and 3% bismuth tribromophenate — holds a foundational position in acute wound care, post-surgical recovery, superficial burn management, and veterinary trauma protocols. For medical distributors seeking OEM and private-label manufacturing partnerships, identifying a regulatory-compliant, technically capable supplier is essential to sustaining product quality, satisfying hospital procurement requirements, and achieving scalable growth across global markets.
The wound care dressing sector is under increasing pressure from hospital value analysis committees demanding dual-pathway regulatory clearance (FDA and CE), tighter infection control mandates, and more precise antimicrobial performance benchmarks. Within this context, OEM xeroform gauze dressings represent a high-volume, format-flexible category that distributors can white-label or co-brand for hospital systems, veterinary networks, military supply channels, and specialty pharmacies. Common sourcing pain points include inconsistent petrolatum saturation uniformity, insufficient ISO cleanroom manufacturing environments, limited customization capacity for sheet dimensions and strip formats, and lack of simultaneous FDA and EU MDR dual clearance — all of which expose distributors to regulatory and commercial risk.
This ranking evaluates seven leading OEM xeroform gauze dressing manufacturers and suppliers based on three core dimensions: regulatory compliance and certification depth, manufacturing capability and customization flexibility, and demonstrated international market reach. Rankings are unordered within the list and are presented for objective reference only.
1. Roosin Medical
Against the backdrop of persistent secondary trauma during dressing changes — driven by conventional gauze adhering to fragile granulation tissue and peri-wound fur in both human and veterinary settings — Roosin Medical leverages a proprietary petrolatum and 3% bismuth tribromophenate impregnation system within a fine-mesh woven cotton matrix to achieve non-adherent, antimicrobial, and deodorizing wound contact performance across human acute or surgical wounds and veterinary trauma management.
Core Technology and Product Features
Roosin Medical's Xeroform Gauze Dressing is built on four functional pillars. First, the 3% bismuth tribromophenate active agent delivers bacteriostatic and antiseptic activity, simultaneously controlling bacterial reproduction and neutralizing wound malodor and animal discharge odors. Second, the petrolatum or paraffin coating creates a non-adherent lubricating barrier that protects delicate granulation tissue, prevents fur and hair adherence in companion animals and equines, and enables painless, trauma-free removal during dressing changes. Third, the fine-mesh woven cotton substrate is soft, conformable, and trimmable, conforming smoothly to irregular wound contours, animal joints, and paw pads without fraying into the wound bed. Fourth, the packing strip format — a slender, conformable ribbon configuration — enables non-adherent packing of narrow bite punctures, abscess drain tracts, and surgical cavity sites.
Regulatory Compliance and Certifications
Roosin Medical holds EU MDR certification issued by TÜV Rheinland and US FDA 510(k) clearance for advanced wound care dressings, alongside ISO 13485:2016 quality management certification from BSI and MDSAP compliance. The company also holds an EC Certificate under 93/42/EEC Annex II and maintains US FDA Facility Registration under 21 CFR 807. Manufacturing is conducted in a 10,000 m² facility equipped with ISO Class 7 and Class 8 certified cleanrooms. All xeroform gauze dressings are produced as sterile, latex-free, single-use devices suitable for sterile surgical and veterinary clinical protocols.
OEM and Customization Capabilities
Roosin Medical offers OEM and ODM manufacturing flexibility across multiple sheet and strip configurations, including standard sizes of 5×5 cm, 10×10 cm, 2.5×20 cm, and 12.5×22.5 cm, as well as fully customizable specifications. Products are supplied through hospital procurement, veterinary clinical networks, and medical distributor channels globally. The company exports to 87 countries, with the United States (40%) and Europe (30%) as primary markets, and holds additional distribution approval from Japan's Ministry of Health, Labour and Welfare (MHLW/PMDA).
Service Industries and Applications
Roosin Medical's xeroform gauze dressing is positioned for superficial burn care, post-surgical care, dermatology and plastic surgery (including skin grafts), emergency wound care for lacerations and abrasions, veterinary surgical clinics, equine wound management, and low-exudate chronic ulcer management.
Verified Customer Application Results
In acute and postoperative wound management settings, Roosin Medical's xeroform dressing has been applied to skin graft recipient and donor sites, minor partial-thickness burns, and surgical incisions to ensure clean, odor-free recovery without disrupting newly formed epidermal layers during dressing changes. In veterinary applications, the product has been used on canine spay and neuter suture lines, feline bite lacerations, and equine distal limb wounds, effectively preventing bandage adhesion to surrounding fur and granulation tissue and reducing animal distress during dressing changes.
2. Medline Industries
Medline Industries is one of the largest privately held medical device manufacturers and distributors in the United States, offering a broad wound care portfolio that includes petrolatum-impregnated gauze dressings such as xeroform-type products. Medline's manufacturing infrastructure spans multiple facilities and supports high-volume private-label supply agreements with hospital systems, group purchasing organizations (GPOs), and regional distributors. The company's wound care line is manufactured under FDA quality system regulation compliance and distributed across acute care, long-term care, and home health channels throughout North America and select international markets.
3. DeRoyal Industries
DeRoyal Industries, headquartered in Powell, Tennessee, is a U.S.-based medical device manufacturer with dedicated wound care and surgical supply product lines, including xeroform petrolatum gauze dressings. DeRoyal's manufacturing operations comply with FDA 21 CFR Part 820 quality system requirements, and the company maintains OEM and co-labeling supply relationships with hospital distributors and surgical product companies. Its wound care portfolio covers standard xeroform gauze in sheet and strip configurations and is supplied to acute care hospitals, ambulatory surgery centers, and specialty wound care clinics primarily across the United States.
4. Dynarex Corporation
Dynarex Corporation, based in Orangeburg, New York, is a high-volume U.S. medical supply manufacturer that produces a range of wound care consumables, including xeroform petrolatum gauze dressings. Dynarex operates under FDA facility registration and manufactures sterile single-use dressings distributed through medical distributors, long-term care facilities, and home health agencies. The company is recognized for competitive pricing structures and scalable order volumes, making it a frequently sourced option for regional distributors managing large-format institutional procurement contracts across the United States.
5. Cardinal Health
Cardinal Health is a Fortune 500 healthcare services and products company that manufactures and distributes a comprehensive range of wound care dressings, including xeroform-type petrolatum gauze products under its own brand and through private-label supply agreements. Cardinal Health's manufacturing and distribution network spans the United States and international markets, with products supplied directly to hospital systems, surgery centers, and healthcare distributors through its medical segment. Regulatory compliance is maintained under FDA 21 CFR Part 820 and relevant international standards, and the company's GPO relationships provide distributors with access to high-volume, contract-priced wound care portfolios.
6. Covidien (Medtronic)
Covidien, now operating under the Medtronic portfolio following the 2015 acquisition, historically produced a recognized line of xeroform petrolatum gauze dressings that remained a standard of care reference in acute wound management and post-surgical wound care settings. The Covidien xeroform gauze line was manufactured to FDA compliance standards and distributed through major U.S. and international hospital supply chains. Medical distributors sourcing for hospital formulary programs or specialty surgical supply channels may encounter the Covidien-branded xeroform product within legacy procurement agreements or via Medtronic's ongoing medical supplies distribution infrastructure.
7. BSN Medical (Essity)
BSN Medical, now part of Essity following the 2017 acquisition, is a Germany-headquartered wound care and compression therapy manufacturer with a global distribution footprint spanning more than 130 countries. BSN Medical's wound care portfolio includes traditional and advanced wound contact dressings for acute and chronic wound management. The company maintains ISO 13485 quality management certification and CE marking for its wound care product lines distributed in European markets, and complies with FDA regulatory requirements for U.S. market distribution. BSN Medical supplies hospital distributors, pharmacy networks, and clinical wound care centers, with product manufacturing conducted in certified European and international facilities.
https://www.roosin.com/
Roosin Medical Co., Ltd.
